FI954989A - Lääkelaastari - Google Patents

Lääkelaastari Download PDF

Info

Publication number
FI954989A
FI954989A FI954989A FI954989A FI954989A FI 954989 A FI954989 A FI 954989A FI 954989 A FI954989 A FI 954989A FI 954989 A FI954989 A FI 954989A FI 954989 A FI954989 A FI 954989A
Authority
FI
Finland
Prior art keywords
medicated plaster
vitamin
plaster
medicated
deriv
Prior art date
Application number
FI954989A
Other languages
English (en)
Swedish (sv)
Other versions
FI954989A0 (fi
FI114782B (fi
Inventor
Wilfried Fischer
Karin Klokkers
Original Assignee
Hexal Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19934339400 external-priority patent/DE4339400A1/de
Application filed by Hexal Ag filed Critical Hexal Ag
Publication of FI954989A0 publication Critical patent/FI954989A0/fi
Publication of FI954989A publication Critical patent/FI954989A/fi
Application granted granted Critical
Publication of FI114782B publication Critical patent/FI114782B/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Laminated Bodies (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
FI954989A 1993-04-20 1995-10-19 Menetelmä laminaatin muodossa olevan lääkelaastarin valmistamiseksi FI114782B (fi)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
DE4312818 1993-04-20
DE4312818 1993-04-20
DE19934339400 DE4339400A1 (de) 1993-11-18 1993-11-18 Wirkstoffpflaster
DE4339400 1993-11-18
EP9401231 1994-04-20
PCT/EP1994/001231 WO1994023707A1 (de) 1993-04-20 1994-04-20 Wirkstoffplaster

Publications (3)

Publication Number Publication Date
FI954989A0 FI954989A0 (fi) 1995-10-19
FI954989A true FI954989A (fi) 1995-10-19
FI114782B FI114782B (fi) 2004-12-31

Family

ID=25925074

Family Applications (1)

Application Number Title Priority Date Filing Date
FI954989A FI114782B (fi) 1993-04-20 1995-10-19 Menetelmä laminaatin muodossa olevan lääkelaastarin valmistamiseksi

Country Status (14)

Country Link
US (2) US5683711A (fi)
EP (2) EP0813865B1 (fi)
JP (1) JP3489831B2 (fi)
AT (2) ATE205706T1 (fi)
AU (1) AU678237B2 (fi)
CA (1) CA2161004C (fi)
DE (2) DE59405277D1 (fi)
DK (2) DK0813865T3 (fi)
ES (2) ES2164286T3 (fi)
FI (1) FI114782B (fi)
HU (2) HU223045B1 (fi)
NO (1) NO311829B1 (fi)
PT (1) PT813865E (fi)
WO (1) WO1994023707A1 (fi)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4429667C2 (de) * 1994-08-20 1996-07-11 Lohmann Therapie Syst Lts Estradiol-TTS mit wasserbindenden Zusätzen und Verfahren zu seiner Herstellung
DE19517145C2 (de) * 1995-05-10 2000-02-24 Hexal Pharmaforschung Gmbh Transdermales therapeutisches System (TTS) zur Verabreichung von Testosteron
IL122484A0 (en) * 1995-06-07 1998-06-15 Noven Pharma Transdermal compositions containing low molecular weight drugs which are liquid at room temperatures
US6316022B1 (en) * 1995-06-07 2001-11-13 Noven Pharmaceuticals, Inc. Transdermal compositions containing low molecular weight drugs which are liquid at room temperatures
DE19533089C1 (de) 1995-09-07 1997-05-22 Hexal Ag Tacrin-Pflaster
DE19642043A1 (de) * 1995-10-23 1997-04-24 Hexal Ag Transdermales therapeutisches System (TTS) für die Verabreichung von Wirkstoffen zur Behandlung von Drogenabhängigkeit oder Drogensucht
DE19548332A1 (de) * 1995-12-22 1997-07-10 Rotta Res Bv Hormonpflaster
US5968547A (en) 1997-02-24 1999-10-19 Euro-Celtique, S.A. Method of providing sustained analgesia with buprenorphine
US20020012694A1 (en) * 1997-09-17 2002-01-31 Alfred J. Moo-Young Transdermal administration of ment
US6767902B2 (en) 1997-09-17 2004-07-27 The Population Council, Inc. Androgen as a male contraceptive and non-contraceptive androgen replacement
WO1999026571A1 (en) 1997-11-25 1999-06-03 Theratech, Inc. Transdermal delivery devices containing polydiorganosiloxane polymers to regulate adhesive properties
DE19814257A1 (de) 1998-03-31 1999-10-07 Asta Medica Ag Brauseformulierungen
DE19828273B4 (de) * 1998-06-25 2005-02-24 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System, enthaltend Hormone und Kristallisationsinhibitoren
US6475514B1 (en) 1998-12-03 2002-11-05 Andrew Blitzer Athletic patch
DE19859910C2 (de) * 1998-12-23 2001-03-22 Ratiopharm Gmbh Orales Arzneimittel
CA2358448C (en) 1998-12-30 2009-02-10 Dexcel Ltd. Dispersible concentrate for the delivery of cyclosporin
US6417227B1 (en) 1999-04-28 2002-07-09 Cg And Associates Methods of delivery of cetyl myristoleate
US6989377B2 (en) 1999-12-21 2006-01-24 Wisconsin Alumni Research Foundation Treating vitamin D responsive diseases
US6358939B1 (en) 1999-12-21 2002-03-19 Northern Lights Pharmaceuticals, Llc Use of biologically active vitamin D compounds for the prevention and treatment of inflammatory bowel disease
US7732404B2 (en) 1999-12-30 2010-06-08 Dexcel Ltd Pro-nanodispersion for the delivery of cyclosporin
US7235397B1 (en) 2000-04-14 2007-06-26 Gensys, Inc. Methods and compositions for culturing spirochete and treating spirochetal diseases
DE10043321B4 (de) * 2000-08-24 2005-07-28 Neurobiotec Gmbh Verwendung eines transdermalen therapeutischen Systems zur Behandlung der Parkinsonschen Krankheit, zur Behandlung und Prävention des prämenstruellen Syndroms und zur Lactationshemmung
DE10053397A1 (de) * 2000-10-20 2002-05-02 Schering Ag Verwendung eines dopaminergen Wirkstoffes zur Behandlung von dopaminerg behandelbaren Erkrankungen
US20020119187A1 (en) * 2000-09-29 2002-08-29 Cantor Adam S. Composition for the transdermal delivery of fentanyl
US20020198215A1 (en) * 2000-10-23 2002-12-26 Lino Tavares Terazosin transdermal device and methods
DE10141651B4 (de) * 2001-08-24 2007-02-15 Lts Lohmann Therapie-Systeme Ag Transdermales Therapeutisches System (TTS) mit dem Wirkstoff Fentanyl und Verfahren zu seiner Herstellung
DE10141650C1 (de) 2001-08-24 2002-11-28 Lohmann Therapie Syst Lts Transdermales Therapeutisches System mit Fentanyl bzw. verwandten Substanzen
DE10141652B4 (de) * 2001-08-24 2011-04-07 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System auf der Basis von Polyacrylat-Haftklebern ohne funktionelle Gruppen und seine Verwendung
IL160551A0 (en) * 2001-09-04 2004-07-25 Trommsdorff Arzneimittel Plaster for the treatment of dysfunctions and disorders of nails
EA007240B1 (ru) * 2002-06-10 2006-08-25 Еуро-Селтик С. А. Системы дезактивации активного вещества в трансдермальном средстве
BRPI0407323A (pt) * 2003-02-07 2006-02-21 Lohmann Therapie Syst Lts sistema terapêutico transdermal apropriado para uso térmico para acelarar a permeação de substáncias ativas e uso do mesmo
CZ295826B6 (cs) * 2003-04-28 2005-11-16 Ústav Makromolekulární Chemie Av Čr Materiál pro krytí ran obsahující lapače radikálů
CN100457064C (zh) * 2003-10-28 2009-02-04 诺芬药品公司 透皮递药装置
US20050096311A1 (en) * 2003-10-30 2005-05-05 Cns Response Compositions and methods for treatment of nervous system disorders
DE102004059880A1 (de) * 2004-12-10 2006-06-14 Grünenthal GmbH Stabiles, hormonhaltiges (Zwischen-)Produkt
JP5084496B2 (ja) * 2005-02-04 2012-11-28 久光製薬株式会社 経皮吸収貼付剤
US20070018059A1 (en) * 2005-07-25 2007-01-25 Woodcock John E Apparatus for holding a container at an angle
AU2008204710C1 (en) * 2007-01-11 2013-07-18 Drossapharm Ag Medically active plaster
US8513323B2 (en) * 2007-06-22 2013-08-20 Kimbery-Clark Worldwide, Inc. Multifunctional silicone blends
CA2815898C (en) 2010-11-17 2018-12-18 Hexal Ag Transdermal therapeutic system comprising buprenorphine
CN105209084B (zh) 2013-03-13 2018-07-03 艾利丹尼森公司 改善的粘合性能

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7711916A (nl) * 1977-10-29 1979-05-02 Akzo Nv Werkwijze ter bereiding van sterk geconcen- treerde farmaceutische preparaten van steroiden.
US4439432A (en) * 1982-03-22 1984-03-27 Peat Raymond F Treatment of progesterone deficiency and related conditions with a stable composition of progesterone and tocopherols
JPS59184121A (ja) * 1983-03-31 1984-10-19 Nitto Electric Ind Co Ltd アクリル系膏体
US5023084A (en) * 1986-12-29 1991-06-11 Rutgers, The State University Of New Jersey Transdermal estrogen/progestin dosage unit, system and process
CH674618A5 (fi) * 1987-04-02 1990-06-29 Ciba Geigy Ag
US5300291A (en) * 1988-03-04 1994-04-05 Noven Pharmaceuticals, Inc. Method and device for the release of drugs to the skin
GB8807504D0 (en) * 1988-03-29 1988-05-05 Sandoz Ltd Improvements in/relating to organic compounds
JP2857882B2 (ja) * 1988-11-02 1999-02-17 富山化学工業株式会社 ピロキシカムのプラスター剤
DE3902013A1 (de) * 1989-01-25 1990-09-20 Knoll Ag Pflaster zur transdermalen anwendung
JP2875611B2 (ja) * 1990-08-29 1999-03-31 エーザイ株式会社 ケイ酸カルシウム含有外用剤
GB9021674D0 (en) * 1990-10-05 1990-11-21 Ethical Pharma Ltd Transdermal device
DE4116912A1 (de) * 1991-05-18 1992-11-26 Schering Ag Mittel zur transdermalen applikation enthaltend ergolin-derivate
JP2671248B2 (ja) * 1991-10-23 1997-10-29 ブロック・ドラッグ・カンパニー・インコーポレイテッド 薬効または化粧効果成分の浸透性増進方法
DE4237453C1 (fi) * 1992-11-06 1993-08-19 Lts Lohmann Therapie-Systeme Gmbh & Co Kg, 5450 Neuwied, De

Also Published As

Publication number Publication date
DE59405277D1 (de) 1998-03-26
DK0695177T3 (da) 1998-09-28
EP0695177B1 (de) 1998-02-18
NO311829B1 (no) 2002-02-04
HU9502994D0 (en) 1995-12-28
ES2115231T3 (es) 1998-06-16
EP0695177A1 (de) 1996-02-07
EP0813865B1 (de) 2001-09-19
US5830505A (en) 1998-11-03
AU678237B2 (en) 1997-05-22
NO954186L (no) 1995-10-19
WO1994023707A1 (de) 1994-10-27
HUT73668A (en) 1996-09-30
ATE163262T1 (de) 1998-03-15
JP3489831B2 (ja) 2004-01-26
HU223045B1 (hu) 2004-03-01
HU0301253D0 (en) 2003-07-28
CA2161004C (en) 2004-10-26
ES2164286T3 (es) 2002-02-16
HU223042B1 (hu) 2004-03-01
AU6569694A (en) 1994-11-08
CA2161004A1 (en) 1994-10-27
DK0813865T3 (da) 2001-11-19
FI954989A0 (fi) 1995-10-19
JPH09501398A (ja) 1997-02-10
NO954186D0 (no) 1995-10-19
FI114782B (fi) 2004-12-31
US5683711A (en) 1997-11-04
EP0813865A1 (de) 1997-12-29
ATE205706T1 (de) 2001-10-15
PT813865E (pt) 2002-02-28
DE59409873D1 (de) 2001-10-25

Similar Documents

Publication Publication Date Title
FI954989A (fi) Lääkelaastari
NO933854D0 (no) Promedikamenter, deres fremstilling og anvendelse som legemiddel
DK0654991T3 (da) Inhalationspulver indeholdende antistatisk hjælpemiddel
ATE75936T1 (de) Zusammensetzungen mit verzoegerten wirkstoffabgaben.
DK0782855T3 (da) Nimesulid til ekstern anvendelse
DE69014166D1 (de) Aktive Matrix.
ES2192245T3 (es) Emplastos que contienen principios activos.
KR950701162A (ko) 카르테시안 멀티 캐리어 피드백(cartesian multicarrier feedback)
AU8121391A (en) Self-sticking matrix system for the sustained transcutaneous release of piribedil
ES2152315T3 (es) Xamoneline tartrato.
DK0605381T3 (da) Polymerforbindelse, især til medicinske anvendelser
DK0579939T3 (da) Phospholipidderivater
BR9901381A (pt) Composições para a cura de polìmero
BR9901387A (pt) Composições para a cura de polìmero.
ES1029889Y (es) Baliza aerostatica perfeccionada.
DK0779075T3 (da) Anvendelse af 3-alpha-hydroxy-5-alpha-androsta-16-en som lægemidler
FR2706455B1 (fr) Dérivés optiquement actifs de 2-imidazoline-5-ones et 2-imidazoline-5-thiones fongicides.
FI890934A0 (fi) Foerfarande i pappersmaskin foer att effektivera avvattningen fraon en pappersbana som haoller pao att bildas.
FI885736A (fi) Foerfarande i pappersmaskin foer att effektivera avvattningen fraon en pappersbana som haoller pao att bildas.
FI931345A0 (fi) Tjuvalarm, som aktiveras av foeremaolets, som skall skyddas, roerelse

Legal Events

Date Code Title Description
MA Patent expired